Zuprevo
PLEASE NOTE: A prescription issued by a UK registered vet (MRCVS) is required before this item can be dispatched.
Zuprevo 180mg/ml Injection
Product Description
For the treatment and prevention of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni sensitive to tildipirosin.
The presence of the disease in the herd should be confirmed before preventive treatment.
Dosage & Administration
Subcutaneous use.
- Administer 4 mg tildipirosin/kg body weight (equivalent to 1 ml/45 kg body weight) once only.
- For treatment of cattle over 450 kg body weight, divide the dose so that no more than 10 ml are injected at one site.
- The rubber stopper of the vial may be safely punctured up to 20 times. Otherwise, the use of a multiple-dose syringe is recommended.
- To ensure correct dosage, bodyweight should be determined as accurately as possible to avoid underdosing.
- It is recommended to treat animals in the early stages of the disease and to evaluate the response to treatment within 2 to 3 days after injection.
- If clinical signs of respiratory disease persist or increase, treatment should be changed using another antibiotic, and continued until clinical signs have resolved.
Withdrawals
Cattle
- Meat and offal: 47 days.
- Not authorised for use in lactating animals producing milk for human consumption.
- Do not use in pregnant animals, which are intended to produce milk for human consumption, within 2 months of expected parturition
50ml
